drugset / Trial / NCT00629928
Ulcer Prevention II
RandomizedParallel-groupDouble-blindPrevention
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers, in patients deemed to be at risk, with either esomeprazole 40 mg once daily; esomeprazole 20 mg once daily.
Timeline
- Start
- 2001-02
- Primary completion
- 2003-03
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |